200 related articles for article (PubMed ID: 29156992)
1. Evaluation Fucoidan Extracts From Undaria pinnatifida and Fucus vesiculosus in Combination With Anticancer Drugs in Human Cancer Orthotopic Mouse Models.
Burney M; Mathew L; Gaikwad A; Nugent EK; Gonzalez AO; Smith JA
Integr Cancer Ther; 2018 Sep; 17(3):755-761. PubMed ID: 29156992
[TBL] [Abstract][Full Text] [Related]
2. Preclinical Evaluation of Safety of Fucoidan Extracts From Undaria pinnatifida and Fucus vesiculosus for Use in Cancer Treatment.
Mathew L; Burney M; Gaikwad A; Nyshadham P; Nugent EK; Gonzalez A; Smith JA
Integr Cancer Ther; 2017 Dec; 16(4):572-584. PubMed ID: 29096568
[TBL] [Abstract][Full Text] [Related]
3. An antithrombotic fucoidan, unlike heparin, does not prolong bleeding time in a murine arterial thrombosis model: a comparative study of Undaria pinnatifida sporophylls and Fucus vesiculosus.
Min SK; Kwon OC; Lee S; Park KH; Kim JK
Phytother Res; 2012 May; 26(5):752-7. PubMed ID: 22084059
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of Active Hexose Correlated Compound (AHCC) in Combination With Anticancer Hormones in Orthotopic Breast Cancer Models.
Mathew L; Gaikwad A; Gonzalez A; Nugent EK; Smith JA
Integr Cancer Ther; 2017 Sep; 16(3):300-307. PubMed ID: 28438054
[TBL] [Abstract][Full Text] [Related]
5. Comparative study on neuroprotective activities of fucoidans from Fucus vesiculosus and Undaria pinnatifida.
Alghazwi M; Smid S; Karpiniec S; Zhang W
Int J Biol Macromol; 2019 Feb; 122():255-264. PubMed ID: 30401646
[TBL] [Abstract][Full Text] [Related]
6. Fucoidan Extracted from the New Zealand
Lu J; Shi KK; Chen S; Wang J; Hassouna A; White LN; Merien F; Xie M; Kong Q; Li J; Ying T; White WL; Nie S
Mar Drugs; 2018 Nov; 16(12):. PubMed ID: 30469516
[TBL] [Abstract][Full Text] [Related]
7. Anti-Metabolic Syndrome Effects of Fucoidan from
Wang X; Shan X; Dun Y; Cai C; Hao J; Li G; Cui K; Yu G
Molecules; 2019 Sep; 24(18):. PubMed ID: 31547311
[TBL] [Abstract][Full Text] [Related]
8. The Effect of Undaria pinnatifida Fucoidan on the Pharmacokinetics of Letrozole and Tamoxifen in Patients With Breast Cancer.
Tocaciu S; Oliver LJ; Lowenthal RM; Peterson GM; Patel R; Shastri M; McGuinness G; Olesen I; Fitton JH
Integr Cancer Ther; 2018 Mar; 17(1):99-105. PubMed ID: 28008779
[TBL] [Abstract][Full Text] [Related]
9. Comparison of in vitro and in vivo antioxidant activities of commercial fucoidans from Macrocystis pyrifera, Undaria pinnatifida, and Fucus vesiculosus.
Silva MMCL; Dos Santos Lisboa L; Paiva WS; Batista LANC; Luchiari AC; Rocha HAO; Camara RBG
Int J Biol Macromol; 2022 Sep; 216():757-767. PubMed ID: 35870628
[TBL] [Abstract][Full Text] [Related]
10. Revised structure model of norovirus-binding fucoidan from Undaria pinnatifida: oligofucose chains branch off from a β6-galactane.
Hanisch FG
Glycobiology; 2023 Aug; 33(7):556-566. PubMed ID: 37184243
[TBL] [Abstract][Full Text] [Related]
11. Preclinical Evaluation of Safety of Fucoidan Extracts From
Bovet L; Samer C; Daali Y
Integr Cancer Ther; 2019; 18():1534735419876325. PubMed ID: 31522564
[No Abstract] [Full Text] [Related]
12. Fucoidan from Fucus vesiculosus prevents the loss of dopaminergic neurons by alleviating mitochondrial dysfunction through targeting ATP5F1a.
Xing M; Li G; Liu Y; Yang L; Zhang Y; Zhang Y; Ding J; Lu M; Yu G; Hu G
Carbohydr Polym; 2023 Mar; 303():120470. PubMed ID: 36657849
[TBL] [Abstract][Full Text] [Related]
13. Investigation of Different Molecular Weight Fucoidan Fractions Derived from New Zealand
Yang X; Wang S; Trangle SS; Li Y; White WL; Li J; Ying T; Kong Q; Zhao Y; Lu J
Mar Drugs; 2018 Nov; 16(11):. PubMed ID: 30453677
[TBL] [Abstract][Full Text] [Related]
14. Fucoidan extract enhances the anti-cancer activity of chemotherapeutic agents in MDA-MB-231 and MCF-7 breast cancer cells.
Zhang Z; Teruya K; Yoshida T; Eto H; Shirahata S
Mar Drugs; 2013 Jan; 11(1):81-98. PubMed ID: 23303302
[TBL] [Abstract][Full Text] [Related]
15. Combining the farnesyltransferase inhibitor lonafarnib with paclitaxel results in enhanced growth inhibitory effects on human ovarian cancer models in vitro and in vivo.
Taylor SA; Marrinan CH; Liu G; Nale L; Bishop WR; Kirschmeier P; Liu M; Long BJ
Gynecol Oncol; 2008 Apr; 109(1):97-106. PubMed ID: 18237771
[TBL] [Abstract][Full Text] [Related]
16. Fucoidan from
Chen Y; Li X; Gan X; Qi J; Che B; Tai M; Gao S; Zhao W; Xu N; Hu Z
Mar Drugs; 2019 Nov; 17(12):. PubMed ID: 31771286
[TBL] [Abstract][Full Text] [Related]
17. The role of the polyamine catabolic enzymes SSAT and SMO in the synergistic effects of standard chemotherapeutic agents with a polyamine analogue in human breast cancer cell lines.
Pledgie-Tracy A; Billam M; Hacker A; Sobolewski MD; Woster PM; Zhang Z; Casero RA; Davidson NE
Cancer Chemother Pharmacol; 2010 May; 65(6):1067-81. PubMed ID: 19727732
[TBL] [Abstract][Full Text] [Related]
18. Modulation of drug resistance in ovarian adenocarcinoma by enhancing intracellular ceramide using tamoxifen-loaded biodegradable polymeric nanoparticles.
Devalapally H; Duan Z; Seiden MV; Amiji MM
Clin Cancer Res; 2008 May; 14(10):3193-203. PubMed ID: 18483388
[TBL] [Abstract][Full Text] [Related]
19. Oral Fucoidan Attenuates Lung Pathology and Clinical Signs in a Severe Influenza a Mouse Model.
Richards C; Williams NA; Fitton JH; Stringer DN; Karpiniec SS; Park AY
Mar Drugs; 2020 May; 18(5):. PubMed ID: 32397317
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of phosphatidylinositol 3'-kinase increases efficacy of paclitaxel in in vitro and in vivo ovarian cancer models.
Hu L; Hofmann J; Lu Y; Mills GB; Jaffe RB
Cancer Res; 2002 Feb; 62(4):1087-92. PubMed ID: 11861387
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
